📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: EpiBiologics

1.1 - Company Overview

EpiBiologics Logo

EpiBiologics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of antibody-based targeted therapies and platforms for tissue-specific degradation of disease-driving membrane and extracellular proteins, including the EpiTAC platform (bispecific antibody system), AbTACs, KineTACs, TrainTAC degrader, and the EpiAtlas platform with a library of over 270 degrader arms.

Products and services

  • EpiTAC Platform: Bispecific system for targeted protein degradation of disease-driving membrane and extracellular proteins with tissue specificity, focusing on targets implicated at cell surfaces and in the extracellular space
  • EpiAtlas platform: Library of over 270 degrader arms targeting various receptors to enable cell- or tissue-specific protein degradation for membrane and extracellular targets
  • TrainTAC degrader: Lysosomal degradation modality employs a broad array of internalizing receptors for degradation of membrane and soluble extracellular proteins

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to EpiBiologics

BaroFold Logo

BaroFold

HQ: United States Website
  • Description: Provider of protein therapeutics for immunology indications, focused on discovering, developing and commercializing protein biologics, some incorporating its proprietary PreEMT high-pressure folding technology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BaroFold company profile →
Gyre Therapeutics Logo

Gyre Therapeutics

HQ: United States Website
  • Description: Provider of protease therapeutics to address disorders of the coagulation system, operating as a biopharmaceutical company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Gyre Therapeutics company profile →
Telavant Logo

Telavant

HQ: United States Website
  • Description: Provider of novel medicines in development to assist patients suffering from inflammatory and fibrotic disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Telavant company profile →
ImmuPharma Logo

ImmuPharma

HQ: United Kingdom Website
  • Description: Provider of drug discovery and development focused on pioneering, novel therapies in specialist therapeutic areas with few existing treatments. Pipeline includes P140 (Lupuzor) in Phase 3 for SLE, P140 in Phase 2/3 for CIDP, BioAMB (amphotericin-B variant) in preclinical for serious fungal infections, and BioCIN (vancomycin-based) in preclinical for severe bacterial infections.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ImmuPharma company profile →
Mount Tam Biotech Logo

Mount Tam Biotech

HQ: United States Website
  • Description: Provider of services to develop, optimize, and bring to market novel pharmaceuticals.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mount Tam Biotech company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for EpiBiologics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to EpiBiologics

2.2 - Growth funds investing in similar companies to EpiBiologics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for EpiBiologics

4.2 - Public trading comparable groups for EpiBiologics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to EpiBiologics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About EpiBiologics

What does EpiBiologics do?

EpiBiologics is a provider of antibody-based targeted therapies and platforms for tissue-specific degradation of disease-driving membrane and extracellular proteins, including the EpiTAC platform (bispecific antibody system), AbTACs, KineTACs, TrainTAC degrader, and the EpiAtlas platform with a library of over 270 degrader arms.

Who are EpiBiologics's competitors?

EpiBiologics's competitors and similar companies include BaroFold, Gyre Therapeutics, Telavant, ImmuPharma, and Mount Tam Biotech.

Where is EpiBiologics headquartered?

EpiBiologics is headquartered in United States.

How many employees does EpiBiologics have?

EpiBiologics has 1,000 employees 🔒.

When was EpiBiologics founded?

EpiBiologics was founded in 2010 🔒.

What sector and industry vertical is EpiBiologics in?

EpiBiologics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for EpiBiologics

Who are the top strategic acquirers in EpiBiologics's sector and industry

Top strategic M&A buyers and acquirers in EpiBiologics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for EpiBiologics?

Top strategic M&A buyers groups and sectors for EpiBiologics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in EpiBiologics's sector and industry vertical

Which are the top PE firms investing in EpiBiologics's sector and industry vertical?

Top PE firms investing in EpiBiologics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in EpiBiologics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in EpiBiologics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in EpiBiologics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to EpiBiologics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in EpiBiologics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for EpiBiologics?

The key public trading comparables and valuation benchmarks for EpiBiologics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for EpiBiologics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for EpiBiologics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in EpiBiologics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for EpiBiologics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in EpiBiologics's' sector and industry vertical?

Access recent funding rounds and capital raises in EpiBiologics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for EpiBiologics